CGRP May Offer Both Migraine Treatment and Prevention ...Middle East

Oral rimegepant, the first calcitonin gene-related peptide (CGRP) receptor antagonist approved for the acute treatment of migraine, was superior to placebo in preventing migraine in a phase 2/3 trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( CGRP May Offer Both Migraine Treatment and Prevention )

Also on site :

• Opinion: Tolerance of diversity is central to San Diego’s economic growth
• ‘Deeply concerned’ over India press censorship, says X as accounts blocked
• Doctor accused of abusing patients treated California hospital like a ‘sexual playground,’ attorneys allege